LInformation Letter on Roferon®-A (interferon alfa-2a)
2013.08.07
Active substance: interferon alfa-2a
The marketing authorisation holder Roche Pharma is circulating an information letter on a temporary shortage in the supply of Roferon®-A due to relocation of the production site.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN